Financials
- Market Capitalization 415.69 M
- Employee 200
- Founded 2015
- CEO N/A
- Website www.ars-pharma.com
- Headquarter Delaware, United States
- FIGI BBG00FZQGXG3
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.7
ratio cours/chiffre d'affaires
13.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2955 | PRTA Prothena Corporation plc - Ordinary Shares | 8.43 USD | -4.64% | +1.81% | -5.81% | -18.31% | 432.77 M USD | ||
| 2977 | EDIT Editas Medicine, Inc. - Common Stock | 2.75 USD | -5.17% | -3.51% | +2.23% | -20.06% | 422.35 M USD | ||
| 2990 | DRUG Bright Minds Biosciences Inc. - common stock | 54.01 USD | -0.07% | +8.21% | -14.04% | -14.27% | 412.41 M USD | ||
| 3002 | AVIR Atea Pharmaceuticals, Inc. - common stock | 5.03 USD | -2.33% | -2.52% | -5.27% | +56.70% | 403.43 M USD |